Aspen Aerogels/$ASPN
1D1W1MYTD1Y5YMAX
Capital at risk
About Aspen Aerogels
Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology, supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Thermal Barrier segment and the United States market. Some of its products include Pyrogel XTE, Cryogel Z, Spaceloft Subsea, and others.
- Ticker
- $ASPN
- Sector
- Materials
- Primary listing
- NYSE
- Employees
- 854
- Headquarters
- Northborough, United States
- Website
- www.aerogel.com
Aspen Aerogels Metrics
BasicAdvanced
$421M
-
-$1.53
2.97
-
Price and volume
Market cap
$421M
Beta
2.97
52-week high
$9.35
52-week low
$2.30
Average daily volume
822K
Financial strength
Current ratio
2.519
Quick ratio
1.946
Long term debt to equity
0.478
Total debt to equity
0.65
Interest coverage (TTM)
-5.35%
Profitability
EBITDA (TTM)
-41.013
Gross margin (TTM)
16.24%
Net profit margin (TTM)
-62.45%
Operating margin (TTM)
-33.34%
Effective tax rate (TTM)
-0.69%
Revenue per employee (TTM)
$240,000
Management effectiveness
Return on assets (TTM)
-9.17%
Return on equity (TTM)
-50.36%
Valuation
Price to revenue (TTM)
2.074
Price to book
2.18
Price to tangible book (TTM)
2.19
Price to free cash flow (TTM)
12.192
Free cash flow yield (TTM)
8.20%
Free cash flow per share (TTM)
0.416
Growth
Revenue change (TTM)
-49.12%
Earnings per share change (TTM)
-60.57%
3-year revenue growth (CAGR)
2.07%
10-year revenue growth (CAGR)
4.55%
3-year earnings per share growth (CAGR)
6.54%
10-year earnings per share growth (CAGR)
23.82%
What the Analysts think about Aspen Aerogels
Analyst ratings (Buy, Hold, Sell) for Aspen Aerogels stock.
Analyst projections of the future price of Aspen Aerogels stock.
Bulls say / Bears say
Aspen expects a sharp third-quarter recovery: revenue guidance is $65m–$80m and adjusted EBITDA guidance is $7m–$15m. Thermal Barrier revenue rose 81% sequentially in Q2, while Energy Industrial deliveries are expected to accelerate on LNG and subsea projects. (Aspen Aerogels, MarketBeat)
European OEM business is becoming a meaningful second growth engine. Aspen raised its 2026 European Thermal Barrier revenue outlook to $20m–$30m, won a Jaguar Land Rover award covering two vehicle architectures and has an awarded pipeline worth about $135m at full production. (MarketBeat, Aspen Aerogels)
Aspen has substantial unused manufacturing capacity and liquidity if volumes recover. Its September presentation says existing facilities and external supply arrangements can support more than $600m of annual revenue, with $153.4m of cash and a targeted adjusted-EBITDA break-even run rate of about $175m by the end of 2027. (Aspen Aerogels)
The recent demand reset is severe, especially in Thermal Barriers. First-half revenue fell to $87.7m from $156.7m, while Thermal Barrier revenue dropped to $45.8m from $104.1m after a large customer cut its long-term forecast and weaker EV incentives reduced expected adoption. (StockTitan)
The East Providence plant incident remains an execution risk. Aspen expects full production capacity only in the first half of 2027, and its third-quarter EBITDA outlook excludes $5m–$10m of incident-related costs, including expedited freight and temporary external manufacturing. (Aspen Aerogels, MarketBeat)
Profitability and cash generation are still weak. Q2 produced a $23.3m net loss and only a 7% reported gross margin, while cash fell to $151.7m and the company carried a $79.5m term loan plus $10.9m drawn on its revolver; management says longer-term growth will require additional financing. (StockTitan, Simply Wall St)
Data summarised monthly by Lightyear AI. Last updated on 20 Sept 2026.
Aspen Aerogels Financial Performance
Revenues and expenses
Aspen Aerogels Earnings Performance
Company profitability
Upcoming events
No upcoming events
Aspen Aerogels News
AllArticlesVideos
Funds containing Aspen Aerogels
Fund name | Fund size | $ASPN weighting |
|---|---|---|
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.01% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.